Samsung Medical Center
Astrocytoma treatment cost in the Republic of Korea typically runs from $27 for initial specialist assessments to $16,500 for primary surgical interventions. A standard consultation with a neurosurgeon costs between $27 and $100, while a craniotomy ranges from $16,500 to $38,000. Total expenses depend on tumor grade, the necessity of follow-up chemotherapy, and the hospital tier. Patients can save 30–50% compared to the US. Most specialized care is concentrated in Seoul and Incheon.
Typical Astrocytoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Advanced astrocytoma cases benefit from multidisciplinary centers like Samsung Medical Center and Severance Hospital. Samsung Medical Center utilizes Novalis and Da Vinci systems for high-precision tumor removal. For patients prioritized by technology, Seoul National University Bundang Hospital (SNUBH) offers a fully digitalized environment. Complex oncology cases are efficiently handled at Asan Medical Center, the largest multidisciplinary facility in the country.
| Republic of Korea | Turkey | Austria | |
| Craniotomy | from $16,500 | from $5,650 | from $20,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Stereotaxic radiosurgery | - | from $4,500 | from $17,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Halcyon | - | from $5,400 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Astrocytoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Astrocytoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Astrocytoma treatment journey.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
The doctor is a highly regarded pediatric and adult neurosurgeon in South Korea, specializing in endoscopic surgeries, brain tumor removal, and radiosurgery. The doctor is adept at treating both benign and malignant neoplasms, showcasing expertise in advanced neurosurgical techniques.
The doctor is a highly experienced Hematologist-Oncologist with over 26 years of expertise in the field. Specializing in the treatment of colon cancer, hematological oncology, myelomas, and lymphoma, the doctor is proficient in advanced procedures such as Bone Marrow Transplantation, including Alternate Donor and Mismatched Transplants.
With a strong academic background, the doctor holds an M.D. from Yonsei University College of Medicine and a Ph.D. from Sungkyunkwan University College of Medicine. The doctor is also a member of multiple professional societies and has contributed to the field through numerous paper publications.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
Top Korean hospitals for astrocytoma include Samsung Medical Center, Seoul National University Hospital (SNUH), and Asan Medical Center. These JCI-accredited tertiary facilities utilize multidisciplinary tumor boards. They offer advanced neurosurgical technologies like Gamma Knife, Novalis radiosurgery, and heavy ion therapy for complex brain tumors.
Bookimed Expert Insight: While Asan and Samsung lead in sheer volume, Seoul National University Hospital remains a unique choice because the nation's president receives care there. This reflects a level of trust in their diagnostic accuracy. Our data shows SNUH manages approximately 10,700 patients daily. This high volume often leads to faster diagnostic turnaround for complex brain scans.
Patient Consensus: Patients note it is vital to secure a second pathology review before starting treatment. They also emphasize confirming that the hospital has a dedicated international clinic to manage follow-up scheduling and translation.
South Korea uses high-precision radiation and surgical tools to treat astrocytoma while preserving brain function. Advanced options include heavy ion therapy, proton beam radiation, and 5-ALA fluorescence-guided surgery. Facilities like Samsung Medical Center utilize Novalis and IGRT systems for sub-millimeter accuracy during treatment.
Bookimed Expert Insight: While most centers focus on surgery, the volume difference at top facilities is massive. Asan Medical Center performs over 65,000 operations annually. This high frequency across Seoul's major hospitals often correlates with higher proficiency in complex neuro-oncology cases compared to lower-volume regional centers.
Patient Consensus: Patients emphasize the importance of choosing centers that offer both neuronavigation and intraoperative imaging. They note these specific tools provide much-needed confidence that the surgeon can remove the tumor safely.
Multidisciplinary care is the standard protocol for astrocytoma management in South Korea. Specialized tumor boards at JCI-accredited centers integrate neurosurgery, radiation oncology, and medical oncology. These teams follow Korean Society for Neuro-Oncology guidelines. This ensuring patients receive coordinated, personalized treatment plans immediately following diagnosis.
Bookimed Expert Insight: While many countries offer multidisciplinary care, South Korea's model is uniquely high-volume. Data shows clinics like Samsung Medical Center and Severance Hospital manage over 2 million patients annually. This massive scale allows for highly specialized sub-teams that focus only on specific tumor mutations. This level of specialization is rarely found in smaller medical hubs.
Patient Consensus: Patients note that treatment decisions involve multiple specialists rather than a single doctor. They emphasize choosing large academic centers to ensure all departments communicate effectively during complex recovery phases.
International patients can access new drugs and clinical trials in South Korea through specialized oncology centers and expanded access programs. Participation depends on trial eligibility, visa status, and residency requirements. Institutions like Samsung Medical Center and Severance Hospital follow Joint Commission International standards and serve thousands of foreign patients annually.
Bookimed Expert Insight: While South Korea ranks 5th globally for medical tourism requests, trial access is highly centralized. Focusing on the biggest digital institutions like Seoul National University Bundang Hospital is strategic. These centers use advanced electronic systems like BESTcare to manage the complex data tracking required for international trial participants.
Patient Consensus: Patients emphasize that securing a local coordinator is vital for managing repeated scans and follow-up visits. They often find that molecular testing results must be ready before clinics will even consider trial eligibility.
Plan to stay in South Korea for 21 to 30 days for brain tumor surgery. This timeframe ensures medical clearance for air travel. You will spend 4 to 7 days in the hospital for craniotomy and monitoring. An additional 14 days in Seoul is required for follow-up.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and maintains presidential standards. Data shows high-volume centers often utilize advanced imaging like IGRT for stabilization. This efficiency can reduce inpatient days, but neurological monitoring typically prevents discharge before day 5.
Patient Consensus: Patients note that being discharged from the hospital is not the same as being ready to fly. Most emphasize staying locally until brain swelling settles and the surgeon explicitly approves long-haul travel.
Patients with astrocytoma can obtain a medical evaluation from Korean specialists before traveling. Leading Seoul hospitals provide remote reviews of MRI scans and pathology reports. These evaluations help confirm treatment eligibility. Specialists often conduct virtual consultations via telemedicine services to discuss surgical options like craniotomy.
Bookimed Expert Insight: While many search for specific specialists, the clinic infrastructure is the strongest quality indicator in Korea. Samsung Medical Center and Asan Medical Center maintain massive patient volumes, serving over 10,000 outpatients daily. This high frequency in treating complex brain tumors leads to refined diagnostic accuracy during remote record reviews. Choosing clinics with Newsweek rankings often ensures access to integrated AI and digital imaging technologies for more precise evaluations.
Patient Consensus: Patients emphasize sending high-quality MRI discs early to avoid travel for cases that aren't candidates for surgery. They note that having translated pathology reports ready significantly speeds up the specialist's feedback.